Compare HHS & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HHS | RPID |
|---|---|---|
| Founded | 1923 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 34.7M |
| IPO Year | 1994 | 2021 |
| Metric | HHS | RPID |
|---|---|---|
| Price | $3.95 | $0.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.75 |
| AVG Volume (30 Days) | 42.0K | ★ 159.1K |
| Earning Date | 11-24-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.35 | 2.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $159,570,000.00 | $33,587,000.00 |
| Revenue This Year | N/A | $16.95 |
| Revenue Next Year | N/A | $17.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $2.00 | $0.58 |
| 52 Week High | $4.67 | $4.94 |
| Indicator | HHS | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 42.50 | 40.38 |
| Support Level | $3.43 | N/A |
| Resistance Level | $4.07 | $2.18 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 68.49 | 67.64 |
Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.